Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: J Thromb Thrombolysis. 2020 Oct;50(3):746–752. doi: 10.1007/s11239-020-02141-4

Table 2.

Patient characteristics and outcomes of patients diagnosed with PPH (N=5,641).

Patient variable Received TXA
(n=106)
Did not receive
TXA (n=5,535)
P
Sector <0.0001
 Central 15 (14.2) 1895 (34.2)
 East 7 (6.6) 1112 (20.1)
 West 84 (79.2) 2528 (45.7)
Year <0.0001
 2015 0 (0.0) 1001 (18.1)
 2016 1 (0.9) 1121 (20.2)
 2017 10 (9.4) 1406 (25.0)
 2018 59 (55.7) 1394 (25.2)
 2019 36 (34.0) 613 (11.5)
History of PPH 35 (33) 368 (7) <0.0001
History of Placenta previa 4 (3.7) 117 (2.1) 0.24
Hematocrit <32% 23 (21.7) 1091 (19.7) 0.61
Gestational Age < 39 weeks 55 (52) 2125 (38) 0.006
Outcomesa
Intensive care unit admission 7 (7) 47 (0.9) <.0001
NICU admission 14 (13) 307 (6) 0.003
Transfusion 3 (3) 401 (7) 0.08
EBL ≥ 1000 ml 106 (100) 5306 (96) 0.02
Delivery type <0.0001
 CD 67 (63.2) 4668 (84.3)
 VBAC 0 (0.0) 16 (0.3)
 Vaginal 39 (36.8) 851 (15.4)

PPH = postpartum hemorrhage; NICU= Neonatal Intensive Care Unit; EBL = Estimated Blood Loss; CD = cesarean delivery; VBAC = vaginal birth after cesarean